Neuromotor and cognitive outcomes of early treatment in tyrosine hydroxylase deficiency type B

Neurology. 2017 Jan 31;88(5):501-502. doi: 10.1212/WNL.0000000000003539. Epub 2016 Dec 30.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / drug therapy*
  • Cognitive Dysfunction / etiology
  • Dopamine Agents / therapeutic use*
  • Dystonic Disorders / complications
  • Dystonic Disorders / congenital*
  • Dystonic Disorders / diagnosis
  • Dystonic Disorders / drug therapy
  • Early Diagnosis
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Motor Skills Disorders / diagnosis
  • Motor Skills Disorders / drug therapy*
  • Motor Skills Disorders / etiology
  • Treatment Outcome

Substances

  • Dopamine Agents
  • Levodopa

Supplementary concepts

  • Segawa syndrome, autosomal recessive